SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-000048
Filing Date
2020-01-03
Accepted
2020-01-03 21:45:38
Documents
1
Period of Report
2019-12-20

Document Format Files

Seq Description Document Type Size
1 form4-01032020_060126.html 4  
1 form4-01032020_060126.xml 4 9235
  Complete submission text file 0001415889-20-000048.txt   10692
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address
BORKOWSKI EDWARD (Reporting) CIK: 0001197542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 20507949

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences